ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRAX Praxis Precision Medicines Inc

47.78
0.00 (0.00%)
Pre Market
Last Updated: 07:21:20
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 45.59
Ask Price 54.86
News -
Day High

Low
12.45

52 Week Range

High
67.21

Day Low
Company Name Stock Ticker Symbol Market Type
Praxis Precision Medicines Inc PRAX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 47.78 07:21:20
Open Price Low Price High Price Close Price Prev Close
47.78
Trades Volume Avg Volume 52 Week Range
0 0 - 12.45 - 67.21
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 47.78 USD

Praxis Precision Medicines (PRAX) Options Flow Summary

Overall Flow

Bullish

Net Premium

28k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Praxis Precision Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
632.53M 13.24M - 2.45M -123.28M -9.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Praxis Precision Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRAX Message Board. Create One! See More Posts on PRAX Message Board See More Message Board Posts

Historical PRAX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week52.2453.0645.0648.26319,449-4.46-8.54%
1 Month60.5567.2145.0655.64373,816-12.77-21.09%
3 Months41.0167.2138.2952.99204,8776.7716.51%
6 Months17.8567.2113.00534.25242,07429.93167.68%
1 Year16.6567.2112.4521.75626,83531.13186.97%
3 Years455.10489.0011.8562.13775,535-407.32-89.50%
5 Years408.15914.257511.8587.70694,599-360.37-88.29%

Praxis Precision Medicines Description

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Your Recent History

Delayed Upgrade Clock